Search research articles
Contact Us
Filters
Showing results (191-200 of 235) with videos related to
Page
of 24
Sort By:
Health Technology Assessment (Winchester, England)
|
November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT
Sam Barratt, Julia A Bielicki, David Dunn, et al.
The Journal of Infectious Diseases
|
April 11, 2022
Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy
Louise Afran, Kondwani C Jambo, Wilfred Nedi, et al.
The New England Journal of Medicine
|
January 24, 2020
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Helen S Marshall, Mark McMillan, Ann P Koehler, et al.
The Pediatric Infectious Disease Journal
|
January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants
Ameneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
BMJ Open
|
May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)
Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Wellcome Open Research
|
November 2, 2019
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
Holly B Bratcher, Charlene M C Rodrigues, Adam Finn, et al.
The Journal of Infection
|
July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of the Royal Society of Medicine
|
July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
Catherine Hyams, George Qian, George Nava, et al.
The Journal of Infectious Diseases
|
September 6, 2021
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis
Mark McMillan, Ann P Koehler, Andrew Lawrence, et al.
The Lancet Regional Health. Europe
|
August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study
Catherine Hyams, Robert Challen, Elizabeth Begier, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 235) with videos related to
Sort By:
Page
of 24
Health Technology Assessment (Winchester, England)
|
November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT
Sam Barratt, Julia A Bielicki, David Dunn, et al.
The Journal of Infectious Diseases
|
April 11, 2022
Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy
Louise Afran, Kondwani C Jambo, Wilfred Nedi, et al.
The New England Journal of Medicine
|
January 24, 2020
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Helen S Marshall, Mark McMillan, Ann P Koehler, et al.
The Pediatric Infectious Disease Journal
|
January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants
Ameneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
BMJ Open
|
May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)
Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Wellcome Open Research
|
November 2, 2019
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
Holly B Bratcher, Charlene M C Rodrigues, Adam Finn, et al.
The Journal of Infection
|
July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of the Royal Society of Medicine
|
July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
Catherine Hyams, George Qian, George Nava, et al.
The Journal of Infectious Diseases
|
September 6, 2021
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis
Mark McMillan, Ann P Koehler, Andrew Lawrence, et al.
The Lancet Regional Health. Europe
|
August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study
Catherine Hyams, Robert Challen, Elizabeth Begier, et al.
Page
of 24